Related Experiment Video
Updated: Mar 24, 2026
06:36
Establishment of Central Cord Syndrome Model in C57BL/6J Mouse
Published on: September 8, 2023
1.3K
Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
Randy Neblett1, Meredith M Hartzell1, Tom G Mayer2
1PRIDE Research Foundation, Dallas, Texas, U.S.A.
Summary
This study established severity levels for the Central Sensitization Inventory (CSI) to help identify and manage central sensitivity syndromes (CSS). These validated levels aid clinicians in assessing patient conditions and treatment effectiveness.
Area of Science:
- Pain Medicine
- Rehabilitation Medicine
- Psychosomatic Medicine
Background:
- Central sensitization (CS) is a proposed common etiology for various chronic pain conditions, including fibromyalgia and chronic fatigue syndrome.
- The Central Sensitization Inventory (CSI) is a validated instrument for identifying patients with symptoms potentially related to central sensitivity syndromes (CSS).
- Establishing clear severity levels for the CSI is crucial for consistent interpretation and clinical application.
Purpose of the Study:
- To create and validate distinct severity levels for the Central Sensitization Inventory (CSI).
- To provide a standardized tool for healthcare providers and researchers to interpret CSI scores.
- To enhance the assessment and management of patients with central sensitivity syndromes (CSS).
Main Methods:
- Severity levels for the CSI were defined based on means and standard deviations from existing data: subclinical (0-29), mild (30-39), moderate (40-49), severe (50-59), and extreme (60-100).
- Concurrent validity was assessed in a chronic pain sample by correlating CSI scores with the number of CSS diagnoses, patient-reported history of CSS, and psychosocial measures.
- CSI score distributions were compared between patients with and without CSS diagnoses.
Main Results:
- The CSI score distribution was significantly higher in patients with CSS compared to those without.
- Higher CSI severity levels correlated with an increased number of physician-diagnosed CSS conditions.
- Patients in the extreme CSI severity range reported higher instances of fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, headaches, and anxiety, alongside greater depressive symptoms, disability, sleep disturbance, and pain intensity.
Conclusions:
- The validated CSI severity levels offer a reliable guideline for interpreting patient scores.
- These levels can assist healthcare providers in evaluating the severity of central sensitization symptoms.
- The findings support the use of CSI severity levels for assessing treatment responsiveness in CSS patients.
